Due to the awareness and benefits of goat rearing in developing economies, goats' significance is increasing. Unfortunately, these ruminants are threatened via multiple bacterial pathogens such as enteropathogenic Escherichia coli (EPEC) and its pathotypes. In goat kids and lambs, EPEC causes gastrointestinal disease leading to substantial economic losses for farmers and may also pose a threat to public health via the spread of zoonotic diseases. Management of infection is primarily based on antibiotics, but the need for new therapeutic measures as an alternative to antibiotics is becoming vital because of the advent of antimicrobial resistance (AMR). The current study focuses on the prevalence of enteric diseases, their identification through various molecular techniques viz., SYBR green real-time PCR, conventional PCR based on bfpA gene, PCR based on uspA gene and isolation, purification of naturally occurring phages against three EPEC multi-drug resistant strains isolated from the neonatal goat. Bacteriophages are novel components that can be used to tackle bacterial infections and AMR, where host immune responses and antimicrobial agents become incompetent. It was observed that a PCR based approach is more effective and rapid as compared to phenotypic tests. It was also established that the isolated bacteriophages exhibited potent antibacterial efficacy in-vitro. Hence, bacteriophages, being a natural therapeutic biological agent docking bacterial host, may be explored as a potential alternative to antibiotics in managing public, livestock and environmental health in this troubling situation of AMR.